• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素偶联响应性金纳米颗粒促进细胞内药物递送,克服癌细胞的多药耐药性。

Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.

机构信息

CAS Key Laboratory of Brain Function and Disease, and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, P. R. China.

出版信息

ACS Nano. 2011 May 24;5(5):3679-92. doi: 10.1021/nn200007z. Epub 2011 Apr 12.

DOI:10.1021/nn200007z
PMID:21462992
Abstract

Multidrug resistance (MDR) is a major impediment to the success of cancer chemotherapy. Through the development of a drug delivery system that tethers doxorubicin onto the surface of gold nanoparticles with a poly(ethylene glycol) spacer via an acid-labile linkage (DOX-Hyd@AuNPs), we have demonstrated that multidrug resistance in cancer cells can be significantly overcome by a combination of highly efficient cellular entry and a responsive intracellular release of doxorubicin from the gold nanoparticles in acidic organelles. DOX-Hyd@AuNPs achieved enhanced drug accumulation and retention in multidrug resistant MCF-7/ADR cancer cells when it was compared with free doxorubicin. It released doxorubicin in response to the pH of acidic organelles following endocytosis, opposite to the noneffective drug release from doxorubicin-tethered gold nanoparticles via the carbamate linkage (DOX-Cbm@AuNPs), which was shown by the recovered fluorescence of doxorubicin from quenching due to the nanosurface energy transfer between the doxorubicinyl groups and the gold nanoparticles. DOX-Hyd@AuNPs therefore significantly enhanced the cytotoxicity of doxorubicin and induced elevated apoptosis of MCF-7/ADR cancer cells. With a combined therapeutic potential and ability to probe drug release, DOX-Hyd@AuNPs represent a model with dual roles in overcoming MDR in cancer cells and probing the intracellular release of drug from its delivery system.

摘要

多药耐药性(MDR)是癌症化疗成功的主要障碍。通过开发一种药物传递系统,将阿霉素通过酸不稳定键(DOX-Hyd@AuNPs)与聚乙二醇间隔臂连接到金纳米粒子的表面,我们已经证明,通过高效的细胞内进入和响应酸性细胞器中金纳米粒子内阿霉素的释放,可以显著克服癌细胞的多药耐药性。与游离阿霉素相比,DOX-Hyd@AuNPs 在多药耐药 MCF-7/ADR 癌细胞中实现了增强的药物积累和保留。它在细胞内摄取后响应酸性细胞器的 pH 释放阿霉素,与通过氨基甲酸酯键(DOX-Cbm@AuNPs)连接的阿霉素结合的金纳米粒子的无效药物释放相反,这是通过阿霉素荧光从纳米表面能量转移之间的淬灭恢复证明的阿霉素基组和金纳米粒子。因此,DOX-Hyd@AuNPs 显著增强了阿霉素的细胞毒性,并诱导 MCF-7/ADR 癌细胞的凋亡增加。具有联合治疗潜力和探测药物释放的能力,DOX-Hyd@AuNPs 代表了一种克服癌细胞多药耐药性和探测其药物传递系统从细胞内释放的双重作用的模型。

相似文献

1
Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.阿霉素偶联响应性金纳米颗粒促进细胞内药物递送,克服癌细胞的多药耐药性。
ACS Nano. 2011 May 24;5(5):3679-92. doi: 10.1021/nn200007z. Epub 2011 Apr 12.
2
Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.基于单硫键桥连嵌段共聚物的氧化还原响应性纳米粒子作为克服癌细胞多药耐药性的药物载体。
Bioconjug Chem. 2011 Oct 19;22(10):1939-45. doi: 10.1021/bc200139n. Epub 2011 Sep 9.
3
Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.通过调节介孔硅纳米粒子的壳孔大小来控制多药耐药癌细胞内阿霉素的释放。
ACS Nano. 2011 Dec 27;5(12):9788-98. doi: 10.1021/nn2033105. Epub 2011 Nov 16.
4
Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.用于刺激响应型药物释放和克服多药耐药性的混合脂质包覆的介孔硅。
ACS Appl Mater Interfaces. 2015 Feb 11;7(5):3342-51. doi: 10.1021/am5082793. Epub 2015 Jan 27.
5
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.多功能胶束纳米粒共递送 PDTC 和阿霉素实现主动靶向药物递送并克服多药耐药性。
Biomaterials. 2010 Jul;31(21):5634-42. doi: 10.1016/j.biomaterials.2010.03.066. Epub 2010 Apr 28.
6
Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer.利用 pH 敏感的聚(β-氨基酯)纳米粒共递送阿霉素和 RNA 逆转乳腺癌的多药耐药性。
Biomaterials. 2014 Jul;35(23):6047-59. doi: 10.1016/j.biomaterials.2014.04.025. Epub 2014 May 3.
7
The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.多功能聚合物纳米缀合物在阿霉素靶向细胞和亚细胞递送中的治疗反应。
Biomaterials. 2010 Feb;31(4):757-68. doi: 10.1016/j.biomaterials.2009.09.080. Epub 2009 Oct 8.
8
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.使用聚合物-脂质杂化纳米颗粒系统对多药耐药乳腺癌细胞中阿霉素摄取和滞留增强的机制研究。
J Pharmacol Exp Ther. 2006 Jun;317(3):1372-81. doi: 10.1124/jpet.106.101154. Epub 2006 Mar 17.
9
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.一种 pH 响应介孔硅纳米粒子的多药物递送系统,用于克服多药耐药性。
Biomaterials. 2011 Oct;32(30):7711-20. doi: 10.1016/j.biomaterials.2011.06.066. Epub 2011 Aug 4.
10
Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.载多柔比星介孔硅纳米粒逆转多药耐药:性能与机制。
Nanoscale. 2011 Oct 5;3(10):4314-22. doi: 10.1039/c1nr10580a. Epub 2011 Sep 5.

引用本文的文献

1
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.
2
Biogenically synthesized gold nanocarrier ameliorated antiproliferative and apoptotic efficacy of doxorubicin against lung cancer.生物合成的金纳米载体增强了阿霉素对肺癌的抗增殖和凋亡作用。
Front Pharmacol. 2024 Oct 29;15:1438237. doi: 10.3389/fphar.2024.1438237. eCollection 2024.
3
Review of Gold Nanoparticles: Synthesis, Properties, Shapes, Cellular Uptake, Targeting, Release Mechanisms and Applications in Drug Delivery and Therapy.
金纳米颗粒综述:合成、性质、形状、细胞摄取、靶向性、释放机制以及在药物递送与治疗中的应用
Pharmaceutics. 2024 Oct 16;16(10):1332. doi: 10.3390/pharmaceutics16101332.
4
-Sulfonatocalix[6]arene-Functionalized Gold Nanoparticles: Applications in Drug Delivery and Bioimaging.磺化杯[6]芳烃功能化金纳米粒子:在药物递送和生物成像中的应用
ACS Phys Chem Au. 2024 Jul 22;4(5):522-530. doi: 10.1021/acsphyschemau.4c00027. eCollection 2024 Sep 25.
5
Insights into the Engineered Gold Nanoparticle-Based Remedy for Supplementation Therapy of Ovarian Carcinoma.基于工程化金纳米颗粒的卵巢癌补充疗法的见解
ACS Omega. 2024 Jul 17;9(30):33033-33043. doi: 10.1021/acsomega.4c04134. eCollection 2024 Jul 30.
6
Coprisin/Compound K Conjugated Gold Nanoparticles Induced Cell Death through Apoptosis and Ferroptosis Pathway in Adenocarcinoma Gastric Cells.Coprisin/复合K共轭金纳米颗粒通过凋亡和铁死亡途径诱导胃癌细胞死亡。
ACS Omega. 2024 Jun 4;9(24):25932-25944. doi: 10.1021/acsomega.4c00554. eCollection 2024 Jun 18.
7
Tackling breast cancer with gold nanoparticles: twinning synthesis and particle engineering with efficacy.用金纳米颗粒攻克乳腺癌:孪晶合成与具有疗效的颗粒工程
Nanoscale Adv. 2024 Apr 17;6(11):2766-2812. doi: 10.1039/d3na00988b. eCollection 2024 May 29.
8
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery.受体介导的肿瘤靶向药物递送研究进展
Adv Ther (Weinh). 2019 Jan;2(1). doi: 10.1002/adtp.201800091. Epub 2018 Sep 10.
9
Nanotechnology-based delivery systems to overcome drug resistance in cancer.基于纳米技术的递送系统以克服癌症中的耐药性。
Med Rev (2021). 2024 Feb 20;4(1):5-30. doi: 10.1515/mr-2023-0058. eCollection 2024 Feb.
10
Nanomaterials in Medicine: Understanding Cellular Uptake, Localization, and Retention for Enhanced Disease Diagnosis and Therapy.医学中的纳米材料:理解细胞摄取、定位和滞留以增强疾病诊断与治疗
Aging Dis. 2024 Feb 22;16(1):168-208. doi: 10.14336/AD.2024.0206-1.